Compare stocks
Market: US
UNHUnitedHealth Group
Add stock
Ticker or company
Summary
Traffic light — 10 checks
| Check | UNH4 ✓ 4 — 1 ✕ |
|---|---|
| P/E vs its history | 22,0 |
| P/E vs industry | 22,0 |
| Forward P/E | 17,7 |
| Revenue growth, YoY | +3,3% |
| EPS growth, YoY | −8,6% |
| Net margin | 3,5% |
| Net debt / EBITDA | 1,4 |
| Free cash flow | $22,8 bn |
| Share count over a year | −0,7% |
| Cash runway | n/anot needed |
Metrics
Best WorstNo mark — in between
| Metric · better | UNHTTM | Industry medianTTM |
|---|---|---|
| P/E TTM ↓ | 22,0 | 25,1 |
| Forward P/E ↓ | 17,7 | 16,2 |
| PEG ↓ | 1,5 | 2,2 |
| P/S TTM ↓ | 0,8 | 2,2 |
| EV/EBITDA ↓ | 14,2 | 17,3 |
| P/FCF ↓ | 15,3 | 19,5 |
Price, %
- UNHn/a
Returns
Best WorstNo mark — in between
| Period | UNH |
|---|---|
| 1 year | n/a |
| 3 years | n/a |
| 5 years | n/a |
| All time | n/a |
“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.
Analysts and insiders
Best WorstNo mark — in between
| UNH | |
|---|---|
| Share of “buy” | 84% |
| Beat the forecast | 3 of 4 |
| Average “surprise” | +12,3% |
| Insiders over 12 months | sales $944 910 |
Details are on each stock page.